Automated description from the Alliance of Genome Resources (Release 7.1.0)
Enables kinase binding activity and ubiquitin protein ligase binding activity. Involved in regulation of circadian sleep/wake cycle, sleep. Acts upstream of or within circadian rhythm and negative regulation of transcription by RNA polymerase II. Predicted to be active in cytoplasm and nucleus. Is expressed in several structures, including central nervous system; early conceptus; and oocyte. Human ortholog(s) of this gene implicated in advanced sleep phase syndrome and advanced sleep phase syndrome 3. Orthologous to human PER3 (period circadian regulator 3).